SARS-COV-2 vaccine responses in renal patient populations

BACKGROUND: Dialysis patients and immunosuppressed renal patients are at increased risk of COVID-19 and were excluded from vaccine trials. We conducted a prospective multicentre study to assess SARS-CoV-2 vaccine antibody responses in dialysis patients and renal transplant recipients, and patients r...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Rona M., Cooper, Daniel J., Doffinger, Rainer, Stacey, Hannah, Al-Mohammad, Abdulrahman, Goodfellow, Ian, Baker, Stephen, Lear, Sara, Hosmilo, Myra, Pritchard, Nicholas, Torpey, Nicholas, Jayne, David, Yiu, Vivien, Chalisey, Anil, Lee, Jacinta, Vilnar, Enric, Cheung, Chee Kay, Jones, Rachel B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153874/
https://www.ncbi.nlm.nih.gov/pubmed/35641961
http://dx.doi.org/10.1186/s12882-022-02792-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153874/
https://www.ncbi.nlm.nih.gov/pubmed/35641961
http://dx.doi.org/10.1186/s12882-022-02792-w

Ejemplares similares